You need to inhibit a specific kinase, block a signaling pathway, or modulate an enzyme for your next experiment. You search the literature and find dozens of available compounds, each with published IC50 values, selectivity profiles, and assay data. How do you pick the right one?
Choosing the wrong inhibitor is one of the most expensive mistakes in cell biology and pharmacology research – not because the compounds are costly, but because months of experimental work built on a poorly chosen tool compound produce results that are difficult to interpret, hard to reproduce, and ultimately misleading. This guide walks through the key decision criteria that experienced researchers use when selecting small molecule inhibitors for their studies.
Potency: Understanding IC50 and What It Actually Tells You
The IC50 – the concentration required to inhibit 50% of target activity – is usually the first number researchers look at. A lower IC50 generally means a more potent compound. But IC50 values are more nuanced than they appear.
IC50 is assay-dependent. The same compound tested against the same target in two different assay formats will often give different IC50 values. Substrate concentration, enzyme concentration, incubation time, buffer composition, and temperature all influence the measurement. An IC50 of 5 nM in one lab’s biochemical assay might become 50 nM in another’s. Always compare IC50 values within the same assay system, and be cautious when comparing values from different publications.
Biochemical IC50 ≠ cellular IC50. A compound with a 10 nM biochemical IC50 might show a 1 µM cellular IC50 due to limited cell permeability, protein binding in serum-containing media, efflux pump activity, or intracellular metabolism. If your experiments are cell-based, prioritize compounds with published cellular potency data. If only biochemical data is available, plan to test a broad concentration range in your initial experiments.
Practical potency benchmarks: For biochemical assays, IC50 or Ki values below 100 nM are generally considered potent. For cell-based assays, sub-micromolar activity (IC50 < 1 µM) is a reasonable starting point, with sub-100 nM cellular potency considered excellent.
Selectivity: Often More Important Than Potency
A highly potent but non-selective inhibitor will hit your target – and many others. The resulting biological effects become impossible to attribute to any single target, undermining the interpretability of your experiment.
What selectivity means quantitatively: A compound is generally considered “selective” when it shows greater than 10-fold potency difference for the target over the closest off-target, and “highly selective” at greater than 100-fold. For kinase inhibitors, selectivity is typically assessed against panels of 100-400 kinases, with the “selectivity score” (S-score) reporting the fraction of the panel that the compound inhibits at a given concentration.
Check the selectivity panel, not just the headline claim. A compound described as a “selective PI3Kα inhibitor” may have excellent selectivity over PI3Kβ and PI3Kδ but still inhibit mTOR at concentrations used in cellular assays. Always review the full selectivity profile – not just the target/closest-off-target ratio – before committing to a compound for your studies.
Use published probe criteria when available. The Chemical Probes Portal (chemicalprobes.org) evaluates tool compounds against rigorous selectivity and potency criteria and recommends specific compounds for specific targets. This is an invaluable resource for choosing validated chemical probes.
Solubility and Physicochemical Properties
A compound can be the most potent and selective inhibitor ever published – but if it does not dissolve in your assay system, it is useless.
DMSO solubility: Nearly all small molecule inhibitors dissolve in DMSO at 10-100 mM concentrations. Check the supplier’s datasheet for the maximum recommended DMSO stock concentration. Immunomart’s Targetmol product pages include solubility data for each compound.
Aqueous solubility: This is the real bottleneck. Highly lipophilic compounds may precipitate when diluted from DMSO stock into aqueous assay medium, especially at concentrations above 10 µM. If your experiment requires high compound concentrations, check published kinetic solubility data and consider using co-solvents (Tween-80, cyclodextrin) or salt forms where available.
Cell permeability: For cell-based studies, the compound must cross the cell membrane to reach intracellular targets. Lipophilic compounds generally permeate better, but excessive lipophilicity causes solubility problems. Look for published cell-based activity data as a surrogate indicator of adequate permeability.
Mechanism of Action: Reversible vs. Irreversible, Competitive vs. Allosteric
Reversible inhibitors bind non-covalently and can be washed out. They are preferred when you need dose-dependent, tunable inhibition and when you want to compare multiple time points or recovery kinetics.
Irreversible (covalent) inhibitors form permanent bonds with the target and cannot be washed out. They provide sustained target suppression but complicate dose-response interpretation because activity accumulates over time. They are appropriate when sustained target knockdown is needed or when studying targets with rapid turnover.
Competitive inhibitors bind at the active site and compete with the natural substrate. Their apparent potency decreases at high substrate concentrations (this is why IC50 values for competitive inhibitors are substrate-concentration-dependent).
Allosteric inhibitors bind at sites distinct from the active site. Their potency is substrate-independent, and they often achieve higher selectivity because allosteric sites are less conserved across protein family members. If available for your target, allosteric inhibitors are often superior tool compounds.
Practical Decision Checklist
Before purchasing a compound for your study, work through these questions:
1. Is there published data in the same assay format I plan to use (biochemical, cellular, in vivo)?
2. What is the selectivity profile – and does it cover the family members most likely to confound my results?
3. Is the compound soluble at my working concentration in my assay medium?
4. Is this compound recommended as a chemical probe by independent evaluation (Chemical Probes Portal, Probe Miner)?
5. Has the compound been used in published studies similar to mine, with reproducible results?
6. What is the recommended negative control compound? (Good tool compound papers always publish an inactive analog.)
7. Am I using the compound within its validated concentration range, or am I extrapolating to conditions where off-target effects are likely?
Browse Research Compounds by Target and Pathway
Immunomart distributes Targetmol’s catalog of over 130,000 research-grade small molecules organized by signaling pathway and target. Whether you are looking for kinase inhibitors, epigenetics modulators, PI3K/AKT/mTOR pathway compounds, apoptosis research tools, or PROTAC degraders, each product page includes structure, purity, IC50 data, selectivity profiles, solubility information, and published references. Browse the full small molecule collection.
Disclaimer: All products referenced are for laboratory research use only (RUO). Not for human or animal consumption, diagnostic, or therapeutic use. Always consult published literature and institutional guidelines for your specific research application.
